TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q3 2019 13F Holders as of 9/30/2019

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
30
Total Principal
221M
Shares change
+2.06M
Total reported value, excl. options
$166M
Value change
+$82.2K
Put/Call ratio
0
Number of buys
11
Number of sells
-13
Price
$0.74
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.